|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 28, 2017 ) ReportsWeb.com has announced the addition of the “Pertussis (Whooping Cough) - Pipeline Review, H2 2016” The report outlines the evolution of enterprise content management, and identifies and assesses the best performing vendors in the market.
Summary
Pharmaceutical and Healthcare latest pipeline guide Pertussis (Whooping Cough) - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Pertussis (Whooping Cough) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Pertussis (Whooping Cough) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 12, 3, 5, 1, 9 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1 and 3 molecules, respectively.
Pertussis (Whooping Cough) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/pertussis-pipeline-review-h2-2016
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Pertussis (Whooping Cough) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Pertussis (Whooping Cough) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Pertussis (Whooping Cough) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Pertussis (Whooping Cough) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Pertussis (Whooping Cough) (Infectious Disease)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pertussis (Whooping Cough) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Pertussis (Whooping Cough) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001530743/sample
Few Points from Table of Content:
Pertussis (Whooping Cough) Overview 8
Therapeutics Development 9
Pipeline Products for Pertussis (Whooping Cough) - Overview 9
Pipeline Products for Pertussis (Whooping Cough) - Comparative Analysis 10
Pertussis (Whooping Cough) - Therapeutics under Development by Companies 11
Pertussis (Whooping Cough) - Therapeutics under Investigation by Universities/Institutes 13
Pertussis (Whooping Cough) - Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Pertussis (Whooping Cough) - Products under Development by Companies 17
Pertussis (Whooping Cough) - Products under Investigation by Universities/Institutes 19
Pertussis (Whooping Cough) - Companies Involved in Therapeutics Development 20
Beijing Minhai Biotechnology Co Ltd 20
Beijing Tiantan Biological Products Co Ltd 21
Bharat Biotech International Ltd 22
Biken Inc 23
Biological E Ltd 24
Boryung Pharmaceutical Co Ltd 25
Daiichi Sankyo Company Ltd 26
DBV Technologies SA 27
GlaxoSmithKline Plc 28
Green Cross Corp 29
ILiAD Biotechnologies LLC 30
Indian Immunologicals Ltd 31
Kaketsuken KK 32
LG Life Science LTD 33
NanoBio Corp 34
Panacea Biotec Ltd 35
Sanofi Pasteur SA 36
Serum Institute of India Ltd 37
Shantha Biotechnics Ltd 38
Synthetic Biologics Inc 39
Zydus Cadila Healthcare Ltd 40
Pertussis (Whooping Cough) - Therapeutics Assessment 41
Assessment by Monotherapy Products 41
Assessment by Combination Products 42
Assessment by Target 43
Assessment by Route of Administration 45
Assessment by Molecule Type 47
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001530743/buy/2000
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
